$3,460,000 of THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"P.L. 117-169, the Inflation Reduction Act of 2022; H.R. 4189/S. 2016, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023. S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) included in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA). Pharmacy issues related to the National Defense Authorization Act, FY2026. S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S. 526, Pharmacy Benefit Manager Transparency Act; S. 1040, The Drug Competition and Enhancement Act; S. 1041, The Affordable Prescriptions for Patients Act. Issues related to H.Con.Res. 14/S.Con.Res. 7 (Establishing the congressional budget for the United States Government for fiscal year 2025) and budget reconciliation; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025."
You can find more data on corporate lobbying on Quiver Quantitative.
CI Congressional Stock Trading
Members of Congress have traded $CI stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CI stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 2 purchases worth up to $30,000 on 03/19, 01/15 and 1 sale worth up to $15,000 on 03/03.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/25, 01/13.
- REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 01/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CI Insider Trading Activity
CI insiders have traded $CI stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CI stock by insiders over the last 6 months:
- DAVID CORDANI (Chairman & CEO) sold 26,527 shares for an estimated $8,173,499
- NOELLE K EDER (See Remarks) sold 9,944 shares for an estimated $3,182,080
- NICOLE S JONES (See Remarks) sold 4,904 shares for an estimated $1,511,020
- ELDER GRANGER sold 2,376 shares for an estimated $737,391
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CI Hedge Fund Activity
We have seen 632 institutional investors add shares of CI stock to their portfolio, and 838 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,623,729 shares (+inf%) to their portfolio in Q4 2024, for an estimated $724,516,526
- FMR LLC removed 1,764,916 shares (-12.4%) from their portfolio in Q4 2024, for an estimated $487,363,904
- JPMORGAN CHASE & CO added 1,317,489 shares (+35.0%) to their portfolio in Q4 2024, for an estimated $363,811,412
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,117,751 shares (-9.3%) from their portfolio in Q4 2024, for an estimated $308,655,761
- BOSTON PARTNERS removed 1,080,728 shares (-62.7%) from their portfolio in Q4 2024, for an estimated $298,432,229
- BLACKROCK, INC. removed 751,711 shares (-3.1%) from their portfolio in Q4 2024, for an estimated $207,577,475
- GQG PARTNERS LLC added 737,099 shares (+22.4%) to their portfolio in Q4 2024, for an estimated $203,542,517
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CI Analyst Ratings
Wall Street analysts have issued reports on $CI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cowen & Co. issued a "Buy" rating on 02/03/2025
- Piper Sandler issued a "Overweight" rating on 02/03/2025
- Raymond James issued a "Strong Buy" rating on 01/31/2025
- Morgan Stanley issued a "Overweight" rating on 01/31/2025
To track analyst ratings and price targets for CI, check out Quiver Quantitative's $CI forecast page.
CI Price Targets
Multiple analysts have issued price targets for $CI recently. We have seen 5 analysts offer price targets for $CI in the last 6 months, with a median target of $355.0.
Here are some recent targets:
- Stephen Baxter from Wells Fargo set a target price of $341.0 on 02/04/2025
- Jessica Tassan from Piper Sandler set a target price of $348.0 on 02/03/2025
- John Ransom from Raymond James set a target price of $360.0 on 01/31/2025
- Erin Wright from Morgan Stanley set a target price of $379.0 on 01/31/2025
- Ben Hendrix from RBC Capital set a target price of $355.0 on 01/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
